CN110487883A - A method of element impurity in detection dutasteride's soft capsule - Google Patents

A method of element impurity in detection dutasteride's soft capsule Download PDF

Info

Publication number
CN110487883A
CN110487883A CN201810458446.7A CN201810458446A CN110487883A CN 110487883 A CN110487883 A CN 110487883A CN 201810458446 A CN201810458446 A CN 201810458446A CN 110487883 A CN110487883 A CN 110487883A
Authority
CN
China
Prior art keywords
solution
dutasteride
detection
standard
standard solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810458446.7A
Other languages
Chinese (zh)
Inventor
余爽
刘波
陈艳
徐欣
赵靓
蔡波涛
叶翔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ren Fupuke Pharmaceutical (wuhan) Co Ltd
Original Assignee
Ren Fupuke Pharmaceutical (wuhan) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ren Fupuke Pharmaceutical (wuhan) Co Ltd filed Critical Ren Fupuke Pharmaceutical (wuhan) Co Ltd
Priority to CN201810458446.7A priority Critical patent/CN110487883A/en
Publication of CN110487883A publication Critical patent/CN110487883A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention discloses a kind of methods of element impurity in detection dutasteride's soft capsule.This method includes the following steps: the preparation of (1) sample solution: accurately weighing dutasteride's soft capsule sample, is cleared up in advance to sample, micro-wave digestion, catches up with acid, then cooling, constant volume obtains sample solution;(2) blank solution is prepared;(3) inner mark solution is prepared;(4) standard solution and linear solvent are prepared;(5) it detects and is analyzed with data: carrying out the detection and analysis of element impurity using standard addition method using ICP-MS.Step of the present invention is simple, at low cost, has good measuring accuracy, more extensively, can more effectively control product quality with multielement simultaneous determination.

Description

A method of element impurity in detection dutasteride's soft capsule
Technical field
The present invention relates to drug quality detection fields, and in particular to a kind of to detect element impurity in dutasteride's soft capsule Method.
Background technique
United States Pharmacopeia (USP) announces that the new standard of element impurity in drug was implemented on January 1st, 2018.General rule<232>and <2232>the day exposure limit (PDE) of list and its permission of concern element is defined based on administration route.This time standard update Make USP concern element list and PDE in terms of with human drugs registration technology requirement coordination committee (ICH) Q3D fourth stage file Match.In June, 2016, FDA issued the guideline for covering the element impurity of ICH Q3D in drug.And dutasteride is soft Capsule should be able to accurately be detected the content of element impurity in the drug by compliance requirement analysis method, to ensure its safety. 7 kinds 1 grade must measured in oral preparation and 2A grades of elements are specified in USP general rule<232>, and soft in dutasteride It is specific during the production of raw medicine of capsule to joined palladium element.Current most of measuring method can only measure one every time Element, and some analysis method detection cycles are long, method is complicated for operation, and consumption reagent is also more, cannot fully meet enterprise Fast and accurately analysis requires.A set of analysis method scientific and effective, that 8 kinds of elemental impurity levels can be measured simultaneously is established, it is right In more extensively, more effectively control product quality, have important application value.
Summary of the invention
The object of the present invention is to provide a kind of ICP-MS (inductivity coupled plasma mass spectrometry) methods to detect dutasteride's flexible glue The method of element impurity in capsule more extensively, more effectively controls product quality.
To achieve the object of the present invention, the present invention uses the latest model instrument of platinum Elmer Co., Ltd 2000ICP-MS develops a kind of method that can measure simultaneously 8 kinds of element impurities in the drug, and this method is simple, fast, and energy Accurate quantification measures the elemental impurity levels of low concentration level, is adopted the technical scheme that: using HNO3, HCl, H2O2, Jin Rong Liquid clears up dutasteride's soft capsule sample in advance, micro-wave digestion, catches up with after acid, constant volume to obtain sample solution, utilizes ICP-MS (electricity Feel couple plasma mass spectrometer) using the detection and analysis of standard addition method progress element impurity.
Specifically, the method for the present invention includes following step:
(1) preparation of sample solution: dutasteride's soft capsule sample accurately is weighed, sample is cleared up in advance, microwave disappears It solves, catch up with acid, then cooling, constant volume obtains sample solution;
(2) blank solution is prepared;
(3) inner mark solution is prepared;
(4) standard solution and linear solvent are prepared;
(5) it detects and is analyzed with data: carrying out the detection and analysis of element impurity using standard addition method using ICP-MS.
In the present invention, in the step (1) sample solution the preparation method comprises the following steps: precision to weigh 0.114g dutasteride soft Capsule sample, precision pipette 5mL HNO3, 1mL HCl, 1mL H2O2, 1mL gold solution is added in counteracting tank, disappeared in advance Solution carries out micro-wave digestion after being cooled to room temperature, catching up with acid to liquor capacity after the completion of micro-wave digestion under the conditions of 110 DEG C is 3ml, cold But it to room temperature, shifts solution into 50ml volumetric flask, repeatedly rinses counteracting tank with ultrapure water, be settled to 50ml, shake up to obtain the final product.
In the present invention, blank solution the preparation method comprises the following steps: precision pipettes 5mL HNO in the step (2)3, 1mL HCl, 1mL H2O2, 1mL gold solution is added in counteracting tank, cleared up in advance, carries out micro-wave digestion, micro-wave digestion after being cooled to room temperature Catching up with acid to liquor capacity under the conditions of 110 DEG C after the completion is 3ml, is cooled to room temperature, and shifts solution into 50ml volumetric flask, with super Pure water repeatedly rinses counteracting tank, is settled to 50ml, shakes up to obtain the final product.
In the present invention, in the step (3) inner mark solution the preparation method comprises the following steps: precision pipette 0.35mL internal standard mixing mark Quasi- solution is settled to scale with diluent to 100mL volumetric flask, and wherein internal standard mixed solution is the nitric acid that mass fraction is 5%, Wherein the concentration of Bi, Ge, In, Sc, Tb, Y and Li are 10 μ g/mL.
In the present invention, step (4) the Plays solution includes standard solution A, standard solution B, and standard solution A includes 1ppm Cd, 1ppm Pb, 3ppm As, 6ppm Hg, 10ppm Co, 20ppm V, 40ppm Ni, standard solution B include 10ppm Pd。
In the present invention, in the step (4) linear solvent the preparation method comprises the following steps:
0.25J (std-1) linear solvent: precision pipettes 0.25mL standard solution A, 0.5mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
0.5J (std-2) linear solvent: precision pipettes 0.50mL standard solution A, 1.0mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
1.0J (std-3) linear solvent: precision pipettes 1.0mL standard solution A, 2.0mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
1.5J (std-4) linear solvent: precision pipettes 1.5mL standard solution A, 3.0mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
Wherein, the J is element theory maximum acceptable concentration, as shown in the table:
Preferably, in the present invention, the gold solution the preparation method comprises the following steps: the accurate standard gold solution for pipetting 1000 μ g/mL 1.0mL adds diluent to be settled to 100mL, shakes up to obtain the final product.
Preferably, the present invention in, the diluent the preparation method comprises the following steps: precision pipettes 25.0mL HNO3And 5.0mL HCl is settled to 500ml with ultrapure water, shakes up to obtain the final product.
Preferably, in the present invention, it is as follows that program is cleared up in advance in the step (1) and (2):
Preferably, in the present invention, micro-wave digestion program is as follows in the step (1) and (2):
No. Time/min Power/W Temperature/DEG C
1 10 1600 130
2 5 1600 130
3 20 1600 180
4 20 1600 180
5 30 Natural cooling Lower than 80
In the present invention, the nitric acid refers to that mass fraction is the nitric acid of 67-70%, and hydrogen peroxide refers to that mass fraction is 30- 32% hydrogen peroxide.
The beneficial effects of adopting the technical scheme are that step of the present invention is simple, and it is at low cost, there is good survey Try precision, ICP-MS detection limit is low, and interference is few, and dynamic linear response range is wide, and analytical precision is high, can with multielement simultaneous determination, More extensively, product quality is more effectively controlled.
Detailed description of the invention
Fig. 1 is As (arsenic) elemental standards curve;
Fig. 2 is Cd (cadmium) elemental standards curve;
Fig. 3 is Co (cobalt) elemental standards curve;
Fig. 4 is Hg (mercury) elemental standards curve;
Fig. 5 is Ni (nickel) elemental standards curve;
Fig. 6 is Pb (lead) elemental standards curve;
Fig. 7 is Pd (palladium) elemental standards curve;
Fig. 8 is V (vanadium) elemental standards curve;
Fig. 9 is the testing result of element impurity concentration in sample;
Abscissa is concentration (μ g/L) of each element in linear solvent in Fig. 1-8, and ordinate is each element linear molten The ratio (CPS) of response and internal standard element response in liquid.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to the accompanying drawings and embodiments, right The present invention is further elaborated.Additional aspect and advantage of the invention will be set forth in part in the description, part It will become apparent from the description below, or practice through the invention is recognized.It is only used to solve it should be appreciated that being described below The present invention is released, is not intended to limit the present invention.
Term "comprising" used herein, " comprising ", " having ", " containing " or its any other deformation, it is intended that covering Non-exclusionism includes.For example, composition, step, method, product or device comprising listed elements are not necessarily limited to those and want Element, but may include not expressly listed other elements or such composition, step, method, product or device it is intrinsic Element.
Conjunction " Consists of " excludes any element that do not point out, step or component.If in claim, this Phrase will make claim closed, so that it is not included the material in addition to the material of those descriptions, but relative normal Except rule impurity.When being rather than immediately following after theme in the clause that phrase " Consists of " appears in claim main body, It is only limited to element described in the clause;Other elements are not excluded except the claim as a whole.
Equivalent, concentration or other values or parameter are excellent with range, preferred scope or a series of upper limit preferred values and lower limit When the Range Representation that choosing value limits, this should be understood as specifically disclosing by any range limit or preferred value and any range Any pairing of lower limit or preferred value is formed by all ranges, regardless of whether the range separately discloses.For example, when open When range " 1 to 5 ", described range should be interpreted as including range " 1 to 4 ", " 1 to 3 ", " 1 to 2 ", " 1 to 2 and 4 to 5 ", " 1 to 3 and 5 " etc..When numberical range is described herein, unless otherwise stated, otherwise the range is intended to include its end Value and all integers and score in the range.
Indefinite article "an" before element or component of the present invention (goes out the quantitative requirement of element or component with "one" Occurrence number) unrestriction.Therefore "one" or "an" should be read as including one or at least one, and singular Element or component also include plural form, unless the quantity obviously only refers to singular.
In addition, term " one embodiment " disclosed below, " some embodiments ", " example ", " specific example " or The description of " some examples " etc. means that particular features, structures, materials, or characteristics described in conjunction with this embodiment or example include In at least one embodiment of the present invention or example.In the present specification, schematic expression of the above terms are not required For identical embodiment or example.As long as moreover, technical characteristic involved in each embodiment of the present invention each other it Between do not constitute conflict and can be combined with each other.
The present invention will be further described in detail below with reference to specific embodiments.
Specifically, the method for the present invention includes following step:
(1) preparation of sample solution: precision weighs 0.114g dutasteride's soft capsule sample, and precision pipettes 5mL HNO3, 1mL HCl, 1mL H2O2, 1mL gold solution is added in counteracting tank, cleared up in advance, micro-wave digestion is carried out after being cooled to room temperature, Catching up with acid to liquor capacity after the completion of micro-wave digestion under the conditions of 110 DEG C is 3ml, is cooled to room temperature, transfer solution to 50ml capacity In bottle, repeatedly rinse counteracting tank with ultrapure water, be settled to 50ml, shake up to obtain the final product;
(2) prepare blank solution: precision pipettes 5mL HNO3, 1mL HCl, 1mL H2O2, 1mL gold solution is added to and disappears It solves in tank, is cleared up in advance, micro-wave digestion is carried out after being cooled to room temperature, catches up with acid after the completion of micro-wave digestion under the conditions of 110 DEG C extremely Liquor capacity is 3ml, is cooled to room temperature, and shifts solution into 50ml volumetric flask, repeatedly rinses counteracting tank with ultrapure water, be settled to 50ml shakes up to obtain the final product;
(3) prepare inner mark solution: precision pipettes 0.35mL internal standard mixed standard solution to 100mL volumetric flask, uses diluent It is settled to scale, wherein internal standard mixed solution is the nitric acid that mass fraction is 5%, and wherein Bi, Ge, In, Sc, Tb, Y and Li's is dense Degree is 10 μ g/mL;
(4) standard solution and linear solvent are prepared, wherein standard solution includes standard solution A, standard solution B, and standard is molten Liquid A includes 1ppm Cd, 1ppm Pb, 3ppm As, 6ppm Hg, 10ppm Co, 20ppm V, 40ppm Ni, standard solution B packet Pd containing 10ppm;
(5) it detects and is analyzed with data: carrying out the detection and analysis of element impurity using standard addition method using ICP-MS.
Preferably, to clear up program in advance in the step (1) and (2) as follows:
No. Time/min Temperature/DEG C
1 10 60
2 30 110
Preferably, micro-wave digestion program is as follows in the step (1) and (2):
No. Time/min Power/W Temperature/DEG C
1 10 1600 130
2 5 1600 130
3 20 1600 180
4 20 1600 180
5 30 Natural cooling Lower than 80
The nitric acid refers to that mass fraction is the nitric acid of 67-70%, and hydrogen peroxide refers to that mass fraction is the double of 30-32% Oxygen water.
Preferably, in the present invention, the preparation method of the gold solution is the standard gold solution that precision pipettes 1000 μ g/mL 1.0mL adds diluent to be settled to 100mL, shakes up to obtain the final product.
Preferably, the present invention in, the diluent the preparation method comprises the following steps: precision pipettes 25.0mL HNO3And 5.0mL HCl is settled to 500ml with ultrapure water, shakes up.
Embodiment 1
It calculates maximum to take daily concentration (μ g/g), i.e., element allows maximum to take daily metering (μ g)/dutasteride's soft capsule maximum Metering (g) is taken daily, the results are shown in Table 1.
1 maximum of table takes daily concentration
Calculating elements theoretical maximum safe level (J) value, unit ppb, calculation formula are as follows:
I.e. maximum takes daily concentration (μ g/g)/dilution because of (mL/g), thus obtains each element J value, as shown in table 2.
2 each element J value of table
Note: dilution gfactor=constant volume/example weight weighs sample 0.114g if pressing one embodiment of the present of invention It is diluted to 50mL, then dilution gfactor is 439.
Embodiment 2
The preparation of linear solvent and the drafting of elemental standards curve:
0.25J (std-1) linear solvent: precision pipettes 0.25mL standard solution A, 0.5mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
0.5J (std-2) linear solvent: precision pipettes 0.50mL standard solution A, 1.0mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
1.0J (std-3) linear solvent: precision pipettes 1.0mL standard solution A, 2.0mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
1.5J (std-4) linear solvent: precision pipettes 1.5mL standard solution A, 3.0mL standard solution B to 50mL capacity Bottle, diluent are diluted to scale, shake up to obtain the final product;
It is specific as shown in table 3.
3 linear solvent of table
Each element standard curve is as follows, respectively as shown in figures 1-8.
As (arsenic) elemental standards curve: y=0.008x+0.000 (R=0.999920)
Cd (cadmium) elemental standards curve: y=0.045x+0.000 (R=0.999922)
Co (cobalt) elemental standards curve: y=0.325x+0.000 (R=0.999723)
Hg (mercury) elemental standards curve: y=0.018x+0.000 (R=0.999923)
Ni (nickel) elemental standards curve: y=0.094x+0.000 (R=0.999892)
Pb (lead) elemental standards curve: y=0.120x+0.000 (R=0.999665)
Pd (palladium) elemental standards curve: y=0.247x+0.000 (R=0.997179)
V (vanadium) elemental standards curve: y=0.096x+0.000 (R=0.999715)
Embodiment 3
Precision weighs 0.114g dutasteride's soft capsule sample, and precision pipettes 5mL HNO3, 1mL HCl, 1mL H2O2, 1mL gold solution, is added in counteracting tank, is cleared up in advance, carries out micro-wave digestion after being cooled to room temperature, after the completion of micro-wave digestion in It is 3ml that acid to liquor capacity is caught up under the conditions of 110 DEG C, is cooled to room temperature, and shifts solution into 50ml volumetric flask, multiple with ultrapure water Counteracting tank is rinsed, 50ml is settled to, shakes up up to sample solution, uses ICP-MS (inductively coupled plasma constitution of the invention Spectrum) method detection dutasteride's soft capsule in element impurity.
Element impurity concentration (μ g/g)=C*Dilution Factor*10 in sample-3, wherein C is concentration of element (μ g/ L), Dilution Factor is dilution gfactor, i.e. constant volume/example weight, unit mL/g, testing result such as Fig. 9 institute Show.
Wherein, Conc. indicates instrument detection gained concentration, by sample detection typical case map it is found that 8 kinds of element impurities Concentration it is lower, the results are shown in Table 4.
Concentration of element in 4 sample of table
Element term Instrument detectable concentration Concentration of element in sample
Pb (lead) 0.1111ppb=0.1111 μ g/L 0.1111μg/L*50ml/0.114g*10-3=0.049 μ g/g
Hg (mercury) 0.0346ppb=0.0346 μ g/L 0.0346μg/L*50ml/0.114g*10-3=0.015 μ g/g
Cd (cadmium) - 0.0011ppb=0 μ g/L 0μg/L*50ml/0.114g*10-3=0 μ g/g
As (arsenic) - 0.0228ppb=0 μ g/L 0μg/L*50ml/0.114g*10-3=0 μ g/g
Co (cobalt) 0.0117ppb=0.0117 μ g/L 0.0117μg/L*50ml/0.114g*10-3=0.005 μ g/g
V (vanadium) - 0.0351ppb=0 μ g/L 0μg/L*50ml/0.114g*10-3=0 μ g/g
Ni (nickel) 0.2295ppb=0.2295 μ g/L 0.2295μg/L*50ml/0.114g*10-3=0.101 μ g/g
Pd (palladium) 0.0125ppb=0.0125 μ g/L 0.0125μg/L*50ml/0.114g*10-3=0.005 μ g/g
As it will be easily appreciated by one skilled in the art that the foregoing is merely illustrative of the preferred embodiments of the present invention, not to The limitation present invention, any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should all include Within protection scope of the present invention.

Claims (10)

1. a kind of method of element impurity in detection dutasteride's soft capsule, which is characterized in that this method includes the following steps:
(1) preparation of sample solution: dutasteride's soft capsule sample accurately is weighed, sample is cleared up in advance, micro-wave digestion, is caught up with Acid, then cooling, constant volume, obtains sample solution;
(2) blank solution is prepared;
(3) inner mark solution is prepared;
(4) standard solution and linear solvent are prepared;
(5) it detects and is analyzed with data: carrying out the detection and analysis of element impurity using standard addition method using ICP-MS.
2. the method for element impurity in detection dutasteride's soft capsule according to claim 1, which is characterized in that the step Suddenly in (1) sample solution the preparation method comprises the following steps: precision weighs 0.114g dutasteride's soft capsule sample, precision pipettes 5mL HNO3, 1mL HCl, 1mL H2O2, 1mL gold solution is added in counteracting tank, cleared up in advance, carries out microwave after being cooled to room temperature Resolution, it is 3ml that micro-wave digestion catches up with acid to liquor capacity under the conditions of 110 DEG C after the completion, is cooled to room temperature, transfer solution to 50ml In volumetric flask, repeatedly rinse counteracting tank with ultrapure water, be settled to 50ml, shake up to obtain the final product.
3. the method for element impurity in detection dutasteride's soft capsule according to claim 1, which is characterized in that the step Suddenly in (2) blank solution the preparation method comprises the following steps: precision pipettes 5mL HNO3, 1mL HCl, 1mL H2O2, 1mL gold solution is added to It in counteracting tank, is cleared up in advance, micro-wave digestion is carried out after being cooled to room temperature, catches up with acid under the conditions of 110 DEG C after the completion of micro-wave digestion It is 3ml to liquor capacity, is cooled to room temperature, shifts solution into 50ml volumetric flask, repeatedly rinse counteracting tank, constant volume with ultrapure water To 50ml, shake up to obtain the final product.
4. the method for element impurity in detection dutasteride's soft capsule according to claim 1, which is characterized in that the step Suddenly in (3) inner mark solution the preparation method comprises the following steps: precision pipettes 0.35mL internal standard mixed standard solution to 100mL volumetric flask, use is dilute It releases agent and is settled to scale, wherein internal standard mixed solution is the nitric acid that mass fraction is 5%, wherein Bi, Ge, In, Sc, Tb, Y and Li Concentration be 10 μ g/mL.
5. the method for element impurity in detection dutasteride's soft capsule according to claim 1, which is characterized in that the step Suddenly (4) Plays solution includes standard solution A, standard solution B, and standard solution A includes 1ppm Cd, 1ppm Pb, 3ppm As, 6ppm Hg, 10ppm Co, 20ppm V, 40ppm Ni, standard solution B include 10ppm Pd.
6. the method for element impurity in detection dutasteride's soft capsule according to claim 1, which is characterized in that the step Suddenly in (4) linear solvent the preparation method comprises the following steps:
0.25J linear solvent: precision pipettes 0.25mL standard solution A, 0.5mL standard solution B to 50mL volumetric flask, and diluent is dilute It releases to scale, shakes up to obtain the final product;
0.5J linear solvent: precision pipettes 0.50mL standard solution A, 1.0mL standard solution B to 50mL volumetric flask, and diluent is dilute It releases to scale, shakes up to obtain the final product;
1.0J linear solvent: precision pipettes 1.0mL standard solution A, 2.0mL standard solution B to 50mL volumetric flask, dilutes dilution agent To scale, shake up to obtain the final product;
1.5J linear solvent: precision pipettes 1.5mL standard solution A, 3.0mL standard solution B to 50mL volumetric flask, dilutes dilution agent To scale, shake up to obtain the final product;
Wherein, the J is element theory maximum acceptable concentration, as shown in the table:
7. according to the method for element impurity in the described in any item detection dutasteride's soft capsules of claim 2 and 3, feature exists In, the gold solution the preparation method comprises the following steps: the accurate standard gold solution 1.0mL for pipetting 1000 μ g/mL, adds diluent to be settled to 100mL shakes up to obtain the final product.
8. according to the method for element impurity in the described in any item detection dutasteride's soft capsules of claim 6-7, feature exists In, the diluent the preparation method comprises the following steps: precision pipettes 25.0mL HNO3With 5.0mL HCl, it is settled to 500ml with ultrapure water, It shakes up to obtain the final product.
9. according to the method for element impurity in the described in any item detection dutasteride's soft capsules of claim 2 and 3, feature exists In it is as follows to clear up program in advance in the step (1) and (2):
10. according to the method for element impurity in the described in any item detection dutasteride's soft capsules of claim 2 and 3, feature It is, micro-wave digestion program is as follows in the step (1) and (2):
CN201810458446.7A 2018-05-14 2018-05-14 A method of element impurity in detection dutasteride's soft capsule Pending CN110487883A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810458446.7A CN110487883A (en) 2018-05-14 2018-05-14 A method of element impurity in detection dutasteride's soft capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810458446.7A CN110487883A (en) 2018-05-14 2018-05-14 A method of element impurity in detection dutasteride's soft capsule

Publications (1)

Publication Number Publication Date
CN110487883A true CN110487883A (en) 2019-11-22

Family

ID=68545035

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810458446.7A Pending CN110487883A (en) 2018-05-14 2018-05-14 A method of element impurity in detection dutasteride's soft capsule

Country Status (1)

Country Link
CN (1) CN110487883A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111678972A (en) * 2020-06-19 2020-09-18 广州汇标检测技术中心 Method for detecting impurity elements in bulk drugs
CN113567537A (en) * 2021-07-15 2021-10-29 人福普克药业(武汉)有限公司 Method for determining element impurities in OTC soft capsules by using inductively coupled plasma mass spectrometry technology
CN114487079A (en) * 2021-12-31 2022-05-13 乳源东阳光药业有限公司 Analysis method for measuring elemental impurity silver in rosuvastatin calcium by ICP-MS

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103389277A (en) * 2012-05-08 2013-11-13 辽宁省食品药品检验所 Detection method of chromium content in capsule shell of capsule preparation
CN106404687A (en) * 2016-08-31 2017-02-15 宁夏多维药业有限公司 Inspection method of chromium in gelatin hollow capsule
CN107436324A (en) * 2017-07-31 2017-12-05 重庆药友制药有限责任公司 A kind of detection method of gelatin hollow capsule content of beary metal
CN107875135A (en) * 2017-11-29 2018-04-06 浙江安宝药业有限公司 Megestrol acetate capsule and preparation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103389277A (en) * 2012-05-08 2013-11-13 辽宁省食品药品检验所 Detection method of chromium content in capsule shell of capsule preparation
CN106404687A (en) * 2016-08-31 2017-02-15 宁夏多维药业有限公司 Inspection method of chromium in gelatin hollow capsule
CN107436324A (en) * 2017-07-31 2017-12-05 重庆药友制药有限责任公司 A kind of detection method of gelatin hollow capsule content of beary metal
CN107875135A (en) * 2017-11-29 2018-04-06 浙江安宝药业有限公司 Megestrol acetate capsule and preparation method

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
SAMINA HUSSAIN等: "Validating the Agilent 7700x ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233>", 《WWW.AGILENT.COM/CHEM》 *
张立雯等: "ICP-MS法测定中成药中5种有害元素的方法研究", 《中华中医药杂志(原中国医药学报)》 *
朱琳娇等: "电感耦合等离子体质谱法检测明胶空心胶囊中 10 种元素的含量", 《中国现代应用药学》 *
王同蕾等: "ICP-MS 法测定不同基质保健品中10 种微量元素的方法", 《中国食物与营养》 *
王金玲等: "桂枝茯苓胶囊及药材中多元素ICP-MS测定方法的建立", 《中国中医杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111678972A (en) * 2020-06-19 2020-09-18 广州汇标检测技术中心 Method for detecting impurity elements in bulk drugs
CN113567537A (en) * 2021-07-15 2021-10-29 人福普克药业(武汉)有限公司 Method for determining element impurities in OTC soft capsules by using inductively coupled plasma mass spectrometry technology
CN114487079A (en) * 2021-12-31 2022-05-13 乳源东阳光药业有限公司 Analysis method for measuring elemental impurity silver in rosuvastatin calcium by ICP-MS

Similar Documents

Publication Publication Date Title
CN110487883A (en) A method of element impurity in detection dutasteride&#39;s soft capsule
CN111678972B (en) Method for detecting impurity elements in bulk drugs
CN101435775B (en) Method for measuring impurity elements arsenic, tin antimony in ferromolybdenum
CN108152444B (en) Method for detecting content of free nitric acid in bismuth nitrate solution
CN110988105A (en) Analysis method for determining hydromorphone hydrochloride raw material medicine element impurities
CN110174458A (en) The detection method that lead and total arsenic measure simultaneously in a kind of formulated food additive
CN108303307A (en) A method of quantitatively detecting hyaluronic acid contents in skin preparation
CN104949961B (en) The ICP AES detection methods of Ge element content in Pb-free solder material
CN105044078B (en) A kind of EDTA-2Na complexings resolution measures lead, cadmium, chromium and mercury method in plastics
CN104101576B (en) A kind of method of nickel content in mensure steel
CN106018382A (en) Method for rapidly testing impurity elements in high-purity gold
CN107632011B (en) Method for measuring content of impurity elements in high-purity bismuth
CN107727643A (en) A kind of method of Ti content in inductively coupled plasma atomic emission spectrometry measure manganese metal
CN108693014A (en) A kind of microwave digestion method and its elemental composition detection method of vanadium chromium titanium alloy material
CN107843640A (en) The assessment method of 20 kinds of constituent content uncertainties in honeysuckle
CN110501412A (en) A method of element impurity in detection naproxen sodium soft capsule
CN101710075A (en) Method for measuring microelement in sodium aluminate solution
CN110044999A (en) The detection method of 14 kinds of trace impurity rare earth ion contents in a kind of ultra-pure cerium compound
CN109765216A (en) A kind of method that ICP-OES method measures heavy metal element in Fenbendazole bulk pharmaceutical chemicals
CN110146490A (en) A method of with micro ruthenium element in ICP-OES measurement drug
CN109738251A (en) The method for measuring boron content in carbon material
CN110954386B (en) Chromium element standard substance in form of medicinal hollow capsule, preparation method thereof, kit combination thereof and method for measuring chromium element content
CN105510259B (en) A kind of method directly measuring lead content in electron level diethylene glycol dimethyl ether
CN108344622A (en) The detection method of a variety of metalloid contents in food is detected simultaneously
CN113804673A (en) Method for measuring boron content in glass

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191122

RJ01 Rejection of invention patent application after publication